Literature DB >> 12151206

Synthesis of a cholestane glycoside OSW-1 with potent cytostatic activity.

Jacek W Morzycki1, Agnieszka Wojtkielewicz.   

Abstract

The potent antitumor agent OSW-1 was synthesized from the protected aglycone in different ways. It was proven that direct glycosylation of the aglycone in its hemiketal form could be achieved, affording the protected OSW-1 in a moderate yield. Alternatively, regioselective protection of the triol obtained by reduction of the aglycone, followed by glycosylation, deprotection and oxidation yielded the same OSW-1 derivative. The third approach to this compound consisted of glycosylation of the previously described lactol [Morzycki, J. W.; Gryszkiewicz, A. Polish J. Chem. 2001, 75, 983-989], reaction of the resulting aldehyde with a Grignard reagent, and oxidation. OSW-1 obtained on removal of the protective groups was identical with the natural product.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151206     DOI: 10.1016/s0008-6215(02)00126-x

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  4 in total

1.  A total synthesis of OSW-1.

Authors:  Jie Xue; Peng Liu; Yanbin Pan; Zhongwu Guo
Journal:  J Org Chem       Date:  2007-12-08       Impact factor: 4.354

2.  Effective killing of leukemia cells by the natural product OSW-1 through disruption of cellular calcium homeostasis.

Authors:  Celia Garcia-Prieto; Kausar Begam Riaz Ahmed; Zhao Chen; Yan Zhou; Naima Hammoudi; Ying Kang; Changgang Lou; Yan Mei; Zhendong Jin; Peng Huang
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

3.  Synthesis of biotinylated OSW-1.

Authors:  Ying Kang; Changgang Lou; Kausar Begam Riaz Ahmed; Peng Huang; Zhendong Jin
Journal:  Bioorg Med Chem Lett       Date:  2009-07-14       Impact factor: 2.823

4.  The enzymatic biosynthesis of acylated steroidal glycosides and their cytotoxic activity.

Authors:  Ming Liu; Jian-Qiang Kong
Journal:  Acta Pharm Sin B       Date:  2018-05-01       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.